ZI
ZIVO Bioscience, Inc.
ZIVO · OTC
$3.50 +9.37% (+$0.30)
1M -28.89%
Market Cap $12.4M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 189.62x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
12 /100
Weak Gross margin 32.44%
Net margin 8,388.36%
FCF margin 3,790.06%
Quality
60 /100
Average ROIC 194.30%
ROA 1,241.30%
Asset turnover 0.15x
Debt
0 /100
High Current ratio 0.10x
Int. coverage -141.10x
Debt/Equity N/A
Stability
44 /100
Moderate Beta 0.11x
EPS volatility 10.38%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ZIVO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Bernard Payne
Employees
7
Headquarters
Troy
Evenimente viitoare
02 DEC.
Earnings
Upcoming earnings report